Jack Yongfeng Zhang - Diamond Bar CA, US Mary Ziping Luo - Diamond Bar CA, US Dingyuan Fei - Montclair CA, US Kevin Xie - Anaheim CA, US Jie Fei Ding - Riverside CA, US
International Classification:
A61K 31/663 A61P 19/10
US Classification:
514108
Abstract:
Pharmaceutical compositions for long-term sustained release of bisphosphonate drugs are provided. In one embodiment, the composition includes an aqueous suspension of a solid which includes a salt of a bisphosphonate drug and a salt of pentavalent phosphorus oxoacid. The compositions can be used to treat a variety of bone diseases, including osteoporosis.
Long Term Sustained Release Pharmaceutical Composition Containing Aqueous Suspension Of Bisphosphonate
- Rancho Cucamonga CA, US Mary Ziping Luo - Diamond Bar CA, US Dingyuan Fei - Montclair CA, US Kevin Xie - Anaheim CA, US Jie Fei Ding - Riverside CA, US
International Classification:
A61K 31/663 A61K 9/00
Abstract:
Pharmaceutical compositions for long-term sustained release of bisphosphonate drugs are provided. In one embodiment, the composition includes an aqueous suspension of a solid which includes a salt of a bisphosphonate drug and a salt of pentavalent phosphorus oxoacid. The compositions can be used to treat a variety of bone diseases, including osteoporosis.
Long Term Sustained Release Pharmaceutical Composition Containing Aqueous Suspension Of Bisphosphonate
- Rancho Cucamonga CA, US Mary Ziping Luo - Diamond Bar CA, US Dingyuan Fei - Montclair CA, US Kevin Xie - Anaheim CA, US Jie Fei Ding - Riverside CA, US
International Classification:
A61K 31/663
Abstract:
Pharmaceutical compositions for long-term sustained release of bisphosphonate drugs are provided. In one embodiment, the composition includes an aqueous suspension of a solid which includes a salt of a bisphosphonate drug and a salt of pentavalent phosphorus oxoacid. The compositions can be used to treat a variety of bone diseases, including osteoporosis.